Picotamide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | B01AC03 (WHO) |
Identifiers | |
| |
PubChem (CID) | 4814 |
ChemSpider | 4649 |
UNII | 654G2VCI4Q |
ECHA InfoCard | 100.046.572 |
Chemical and physical data | |
Formula | C21H20N4O3 |
Molar mass | 376.409 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Picotamide is a platelet aggregation inhibitor. It works as a thromboxane synthase inhibitor and a thromboxane receptor inhibitor, the latter by modifying cellular responses to activation of the thromboxane receptor.[1]
References
- ↑ Ratti, S; Quarato, P; Casagrande, C; Fumagalli, R; Corsini, A (1998). "Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes". European Journal of Pharmacology. 355 (1): 77–83. doi:10.1016/S0014-2999(98)00467-1. PMID 9754941.
External links
- Andrea Celestini and Francesco Violi: A review of picotamide in the reduction of cardiovascular events in diabetic patients (PubMed)
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.